Lion Point Capital, LP
- SEC CIK
- 0001643354
- Latest filing
- Aug 14, 2026
FENC holding history
Fennec Pharmaceuticals Inc. in every 13F filed by Lion Point Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FENC overviewAll 13F holders of FENCFull Q2 2026 holdings
- Shares (Q2 2026)
- 112,434
- Value
- $1.21M
- % of portfolio
- 5.8%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 112,434 | $1.21M | 5.8% | 00.0% | Unchanged | Holders |
| Q1 2026 | 112,434 | $691.5K | 4.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 112,434 | $865.7K | 4.5% | −10,566−8.6% | Reduced | Holders |
| Q3 2025 | 123,000 | $1.15M | 6.5% | −72,700−37.1% | Reduced | Holders |
| Q2 2025 | 195,700 | $1.62M | 11.0% | 00.0% | Unchanged | Holders |
| Q1 2025 | 195,700 | $1.19M | 7.6% | 00.0% | Unchanged | Holders |
| Q4 2024 | 195,700 | $1.24M | 6.5% | −19,300−9.0% | Reduced | Holders |
| Q3 2024 | 215,000 | $1.07M | 4.3% | +45,000+26.5% | Added | Holders |
| Q2 2024 | 170,000 | $1.04M | 3.3% | 00.0% | Unchanged | Holders |
| Q1 2024 | 170,000 | $1.89M | 3.6% | +60,000+54.5% | Added | Holders |
| Q4 2023 | 110,000 | $1.23M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 110,000 | $826.1K | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2023 | 110,000 | $971.3K | 0.7% | +110,000 | New | Holders |